• English
  • 简体中文
Login Register
Current Location: Home > Marketing Drugs(EU) Feedback Help
EMA Approvals
-
HMA Approvals
-

EMA:Drugs approved by European Medicines Agency through centralized Procedure. 

HMA:Drugs approved by EU members through Mutual Recognition Procedure.

For more information check in official website of members:

Drug label information in UK

Public Assessment Reports in UK

Marketed drugs in France

Marketed drugs in Italy

Marketed drugs in Switzerland

Marketed drugs in Sweden

Marketed drugs in Germany

Click here for more information

Brand name Nonproprietary Name Authorization date Marketing authorisation holder
Duloxetine Zentiva duloxetine 2015-08-20 Zentiva, k.s.
Duloxetine Mylan duloxetine 2015-06-19 Mylan Pharmaceuticals Limited
Duloxetine Lilly duloxetine 2014-12-08 Eli Lilly Nederland B.V.
Cymbalta duloxetine 2004-12-17 Eli Lilly Nederland B.V.
Nodetrip (previously Xeristar) duloxetine 2004-12-17 Esteve Pharmaceuticals, S.A.
Ariclaim duloxetine 2004-08-11 Eli Lilly Nederland B.V.
Duloxetine Boehringer Ingelheim duloxetine 2008-10-08 Boehringer Ingelheim International GmbH